U.S. Markets open in 1 hr 20 mins

How BioMarin Pharmaceutical’s Financials Look in November

Daniel Collins
How BioMarin Pharmaceutical’s Financials Look in November

BioMarin Pharmaceutical’s (BMRN) net revenues over the first nine months of this year amounted to $1.1 billion compared to $955.3 million in the same period the prior year, a ~19% YoY increase. BioMarin Pharmaceutical reported net revenues of $391.7 million in the third quarter, which reflected ~17% YoY growth.